Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 1;56(2):188-199.
doi: 10.1097/SHK.0000000000001724.

Severe COVID-19: Immunosuppression or Hyperinflammation?

Ye Liu  1   2 , Yiming Li  1   2 , Dongxue Xu  1   2 , Jing Zhang  1   2 , Zhiyong Peng  1   2
Affiliations
Review

Severe COVID-19: Immunosuppression or Hyperinflammation?

Ye Liu et al. Shock. .

Abstract

The ongoing coronavirus disease 2019 (COVID-19) pandemic has swept over the world and causes thousands of deaths. Although the clinical features of COVID-19 become much clearer than before, there are still further problems with the pathophysiological process and treatments of severe patients. One primary problem is with the paradoxical immune states in severe patients with COVID-19. Studies indicate that Severe Acute Respiratory Syndrome Coronavirus 2 can attack the immune system, manifested as a state of immunosuppression with a decrease in lymphocytes, whereas a state of hyperinflammation, presenting as elevated cytokine levels, is also detected in COVID-19. Therefore, discussing the specific status of immunity in COVID-19 will contribute to the understanding of its pathophysiology and the search for appropriate treatments. Here, we review all the available literature concerning the different immune states in COVID-19 and the underlying pathophysiological mechanisms. In addition, the association between immune states and the development and severity of disease as well as the impact on the selection of immunotherapy strategies are discussed in our review.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 382 (8):727–733, 2020.
    1. World Health Organization: Coronavirus disease (COVID-19) outbreak situation. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 . Accessed October 22, 2020.
    1. WHO Director-General's opening remarks at the media briefing on COVID-19-11 March 2020. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re... . Accessed October 22, 2020.
    1. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348 (20):1953–1966, 2003.
    1. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348 (20):1967–1976, 2003.

Publication types